Antithrombotic Therapy for Atrial FibrillationJohn J. You, Gregory Y.H. Lip, Daniel E. Singer et al.|CHEST Journal|2012Cited by 919
Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App TrialYutao Guo, Gregory Y.H. Lip, Yundai Chen et al.|The American Journal of Medicine|2017Cited by 249
Mobile Apps to Improve Medication Adherence in Cardiovascular Disease: Systematic Review and Meta-analysisShahd Al‐Arkee, Zahraa Jalal, Julie Mason et al.|Journal of Medical Internet Research|2021Cited by 205
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on StrokeGregory Y.H. Lip, Tatjana Potpara, Deirdre A. Lane et al.|European Heart Journal|2022Cited by 138
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Robert Scott-Millar, Jean‐Philippe Collet et al.|EP Europace|2017Cited by 137